$BLUE bluebird bio, Inc. Insider Trading Week 23/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. in week 23/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 2,500 | 5,216 | 12,736 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 100.05 | 2,500 | 250,135 | 27,305 | 29.8 K to 27.3 K (-8.39 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 2,500 | 5,216 | 29,805 | 27.3 K to 29.8 K (+9.16 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,263 | 4,722 | 7,008 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 100.14 | 2,263 | 226,622 | 1,400 | 3.7 K to 1.4 K (-61.78 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,263 | 4,722 | 3,663 | 1.4 K to 3.7 K (+161.64 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,000 | 50,510 | 29,500 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 99.04 | 1,500 | 148,560 | 35,779 | 37.3 K to 35.8 K (-4.02 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,000 | 50,510 | 37,279 | 36.3 K to 37.3 K (+2.76 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 50.51 | 435 | 21,972 | 13,500 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 50.51 | 1,740 | 87,887 | 13,935 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 15,070 | 339,527 | 36,812 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 100.05 | 435 | 43,522 | 15,801 | 16.2 K to 15.8 K (-2.68 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 50.51 | 435 | 21,972 | 16,236 | 15.8 K to 16.2 K (+2.75 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 100.22 | 16,810 | 1,684,705 | 15,801 | 32.6 K to 15.8 K (-51.55 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 50.51 | 1,740 | 87,887 | 32,611 | 30.9 K to 32.6 K (+5.64 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 15,070 | 339,527 | 30,871 | 15.8 K to 30.9 K (+95.37 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 1,000 | 2,086 | 9,271 | |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 90.00 | 1,000 | 90,002 | 1,400 | 2.4 K to 1.4 K (-41.67 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 1,000 | 2,086 | 2,400 | 1.4 K to 2.4 K (+71.43 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 1,000 | 2,090 | 9,239 | |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 90.00 | 1,000 | 90,002 | 17,177 | 18.2 K to 17.2 K (-5.50 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 1,000 | 2,090 | 18,177 | 17.2 K to 18.2 K (+5.82 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 750 | 37,883 | 30,500 | |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 76.00 | 400 | 30,400 | 36,279 | 36.7 K to 36.3 K (-1.09 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 75.48 | 1,100 | 83,030 | 36,679 | 37.8 K to 36.7 K (-2.91 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 750 | 37,883 | 37,779 | 37 K to 37.8 K (+2.03 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 2,000 | 4,180 | 10,239 | |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 75.42 | 2,000 | 150,849 | 17,177 | 19.2 K to 17.2 K (-10.43 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 2,000 | 4,180 | 19,177 | 17.2 K to 19.2 K (+11.64 %) |